EMA: Points to consider on implications of COVID-19 on methodological aspects of ongoing clinical trials
The European Medicine Agency (EMA) released a guidance to illustrate some points to consider on implications of COVID-19 on methodological aspects of ongoing clinical trials. "At this point in time it is not possible to provide general advice on [...]